These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 6239841)

  • 1. Studies of immunosuppressive effect of anti-recipient alloantiserum. II. Effect on in vitro MLR and CML.
    Dohi K; Asahara T; Ono E; Yahata H; Fukuda Y
    Hiroshima J Med Sci; 1984 Sep; 33(3):513-9. PubMed ID: 6239841
    [No Abstract]   [Full Text] [Related]  

  • 2. Studies of immunosuppressive effect of anti-recipient alloantiserum. I. Effect on skin graft survival in mice.
    Dohi K; Asahara T; Ono E; Yahata H; Fukuda Y
    Hiroshima J Med Sci; 1984 Sep; 33(3):507-11. PubMed ID: 6392214
    [No Abstract]   [Full Text] [Related]  

  • 3. Inhibition of mixed lymphocyte culture by alloantibodies in renal transplantation and in pregnancy.
    Revillard JP; Robert M; DuPont E; Betuel H; Rifle G; Traeger J
    Transplant Proc; 1973 Mar; 5(1):331-5. PubMed ID: 4266656
    [No Abstract]   [Full Text] [Related]  

  • 4. Transfer factor in transplantation immunobiology.
    Lawrence HS
    Transplant Proc; 1977 Mar; 9(1):1319-26. PubMed ID: 141127
    [No Abstract]   [Full Text] [Related]  

  • 5. An in vitro study of how much methylprednisolone is needed to produce immunosuppression.
    Rosenberg JC; Lysz K
    Proc Clin Dial Transplant Forum; 1977; 7():23-8. PubMed ID: 150598
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Histocompatibility tests in a transplantation program].
    de-Leo-Cervantes C
    Rev Invest Clin; 2005; 57(2):142-6. PubMed ID: 16524052
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tolerance induction against cardiac allograft by anti-ICAM-1 and anti-LFA-1 treatment: T cells respond to in vitro allostimulation.
    Isobe M; Ihara A
    Transplant Proc; 1993 Feb; 25(1 Pt 2):1079-80. PubMed ID: 8095106
    [No Abstract]   [Full Text] [Related]  

  • 8. Immunosuppressive effect of cell-free extracts from Escherichia coli.
    Kirpatovski ID; Stanislavski ES
    Transplant Proc; 1971 Mar; 3(1):831-4. PubMed ID: 4937978
    [No Abstract]   [Full Text] [Related]  

  • 9. Comparison of neonatally and adoptively induced transplantation tolerance in mice.
    Hasek M; Holán V; Chutná J
    Folia Biol (Praha); 1980; 26(3):167-75. PubMed ID: 6448173
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
    Petersen SL
    Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A nonlethal conditioning approach to achieve durable multilineage mixed chimerism and tolerance across major, minor, and hematopoietic histocompatibility barriers.
    Colson YL; Wren SM; Schuchert MJ; Patrene KD; Johnson PC; Boggs SS; Ildstad ST
    J Immunol; 1995 Nov; 155(9):4179-88. PubMed ID: 7594573
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunosuppressive effect of murine alloantibody giving only partial H-2 cover.
    Milton JD
    Transplantation; 1980 Apr; 29(4):339-41. PubMed ID: 7368281
    [No Abstract]   [Full Text] [Related]  

  • 13. Allogeneic bone marrow-derived flk-1+Sca-1- mesenchymal stem cells leads to stable mixed chimerism and donor-specific tolerance.
    Deng W; Han Q; Liao L; Li C; Ge W; Zhao Z; You S; Deng H; Zhao RC
    Exp Hematol; 2004 Sep; 32(9):861-7. PubMed ID: 15345288
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Immunologic enhancement, the solution for transplantation problems].
    Jeekel J
    Ned Tijdschr Geneeskd; 1973 Nov; 117(44):1648-53. PubMed ID: 4274496
    [No Abstract]   [Full Text] [Related]  

  • 15. Studies of alloantibody effect on skin graft survival in mice.
    Dohi K; Asahara T; Ono E; Yahata H; Fukuda Y
    Hiroshima J Med Sci; 1984 Jun; 33(2):271-4. PubMed ID: 6384147
    [No Abstract]   [Full Text] [Related]  

  • 16. Devising murine models to better adapt clinical protocols: sequential low-dose treatment with anti-CD3 and anti-CD4 monoclonal antibodies to prevent fully mismatched allograft rejection.
    Campos HH; Bach JF; Chatenoud L
    Transplant Proc; 1993 Feb; 25(1 Pt 1):798-9. PubMed ID: 8438486
    [No Abstract]   [Full Text] [Related]  

  • 17. Humoral transplantation antibodies.
    Milgrom F
    Transplant Proc; 1999; 31(1-2):30-3. PubMed ID: 10083001
    [No Abstract]   [Full Text] [Related]  

  • 18. Synergistic effects of ATS and passive and active enhancement on heart and skin allografts in rats.
    Rowiński WA; Wasowska BA; Ryffa T; Stepkowski S; Dabrowski M; Tilney NL; Olszewski WL
    Arch Immunol Ther Exp (Warsz); 1983; 31(6):809-17. PubMed ID: 6378133
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of brequinar sodium on accelerated cardiac allograft rejection in presensitized recipients.
    Nozaki S; Ito T; Kamiike W; Uchikoshi F; Yamamoto S; Nakata S; Shirakura R; Miyata M; Matsuda H; Stepkowski SM
    Transplant Proc; 1994 Aug; 26(4):2333-5. PubMed ID: 7520633
    [No Abstract]   [Full Text] [Related]  

  • 20. Photochemical treatment with S-59 psoralen and ultraviolet A light to control the fate of naive or primed T lymphocytes in vivo after allogeneic bone marrow transplantation.
    Truitt RL; Johnson BD; Hanke C; Talib S; Hearst JE
    J Immunol; 1999 Nov; 163(9):5145-56. PubMed ID: 10528221
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.